Inhalation

INH1021

Issue link: https://www.e-digitaleditions.com/i/1417310

Contents of this Issue

Navigation

Page 20 of 37

Inhalation OctOber 2021 19 Connected metered dose inhaler H&T Presspart has developed a market-ready, fully embedded and connected metered dose inhaler, the eMDI™. By tracking and recording data on the use of medications, and sharing it with patients and physicians via a mobile or web app, the eMDI enables pharmaceutical manufacturers to provide an advanced level of care to those with asthma and chronic obstructive pulmonary disease (COPD). e eMDI can improve patients' adherence to med- ication doses, encourage self-care, and help health professionals maintain real-time patient monitoring. H&T Presspart UK: +44 1254 582233 www.presspart.com Integrated, end-to-end services Hovione offers end-to-end service for particle-based and inhalation products. With more than 20 years of expertise in the development and marketing of innovative inhalation devices, we offer dry powder inhalers that are simple, patented and cost-effective. Crystallization, jet milling and wet milling spray- drying processes are developed using a quality by design (QbD) approach to deliver the physical, chem- ical and microbiological critical quality attributes of the active pharmaceutical ingredient. Hovione also offers a complete portfolio of platforms suitable for both innovator and generic development. Hovione Portugal: + 351 21 982 9000 www.hovione.com Dry powder inhalation capsule portfolio Lonza's Capsugel ® Zephyr™ dry powder inhalation capsule portfolio is a comprehensive capsule prod- uct offering, featuring customized DPI capsules and dedicated equipment in place for efficient, phase- appropriate capsule filling. e Zephyr DPI portfolio addresses the need for highly customized solutions for pulmonary route delivery methods and is sup- ported by Lonza's inhalation and drug development and particle engineering capabilities. is integrated product and service offering enables consistent and optimal release performance for inhalation drugs. Lonza Capsules & Health Ingredients US: +1 888 783-6361 www.capsugel.com Automating device testing In a world driven by increasing pressure to improve efficiency, labor utilization and throughput, auto- mating menial tasks is an obvious first step. MSP, a division of TSI, offers a wide range of automated solutions, for performing basic functions to more fully automated operations. Advanced turnkey semi- automation equipment, such as the Vertus II, reduces errors and variation and results in more reliable, con- sistent, dependable data and a streamlined method transfer. Basic automation improves throughput and helps ensure an analyst is working on meaningful and value-added activities. Learn more about how we can help you streamline your process! MSP, a Division of TSI US: +1 651 287-8100 www.TSI.com

Articles in this issue

Links on this page

view archives of Inhalation - INH1021